Third Arc Bio

Series-A
thirdarcbio.com Biotech & Healthcare Boston, United States 11-50
Total Funding $217M
Latest Round $52M Series-A
Last Announced Feb 4, 2026
Investors 16 Backers
Decision Makers 6 Verified

About Third Arc Bio

Third Arc Bio is advancing antibody technology by unlocking the powerful biology of immune synapses to address solid tumors and autoimmune diseases.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Boston, United States
Team Size 11-50
Tracked Since Sep 29, 2026

Web & Domain Identity

Official Website thirdarcbio.com
Domain Registered Date Feb 23, 2024

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $52,000,000 · Series-A

    fundraisingfox.com

  2. Capital Raise

    Raised $165,000,000 · Series-A

  3. Milestone

    Website domain registered

    thirdarcbio.com

Investors & Backers

16
AbbVie
Aberdeen
Alderline Group
Andreessen Horowitz
Biotechnology Value Fund
Cormorant Asset Management
Foresite Capital
Galapagos
Goldman Sachs Alternatives
Hillhouse Investment
Janus Henderson Investors
Logos Capital
Marshall Wace
Omega Funds
T. Rowe Price
Vida Ventures

Funding History

2 Rounds
Series-A · Feb 4, 2026
Series-A · Jul 22, 2024
$165,000,000 Source

Founders & Leadership

1

Sanjaya Singh

Founder and Chief Scientific Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts